Abstracts in Lung Cancer Worth Noting for ASCO 2008
Significant Improvement in Progression-Free Survival in Advanced NSCLC with Alimta
New GRACE Post on Molecular Testing for EGFR: Should It Be Routine Practice?
New Post in GRACE Lung Cancer Section
Biomarkers Predicting Clinical Benefits for BAC Patients Receiving Tarceva
Comment on Bone Metastases in Lung Cancer: An Introduction by Dr. West
Comment on Bone Metastases in Lung Cancer: An Introduction by maruchi2323
Comment on Chemotherapy for Brain Metastases: More Helpful than It’s Given Credit For by Dr. West
Comment on Chemotherapy for Brain Metastases: More Helpful than It’s Given Credit For by Dr. West
Comment on Chemotherapy for Brain Metastases: More Helpful than It’s Given Credit For by jimmy112199
Dr. West on "Taxotere or Tarceva dilema"
Nova on "Behavior due to brain Mets?"
thehoangs on "Taxotere or Tarceva dilema"
Dr. West on "SCLC-ED, treatment/prognosis questions"
I’ve written a couple of posts on what I’d consider to be the top 10 abstracts in lung cancer at the upcoming ASCO conference that are worth discussing further in lung cancer and that I think are likely to have an impact on lung cancer management over the next few years. The list includes some background and commentary on each of these abstracts and is broken into part 1 and part 2.
Loading ...